Sentinel Asset Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
EIP
Sentinel Asset Management's CLB Position: Q4 2017 in Review
Sentinel Asset Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 40,000 shares — an estimated $3.95M sold.
Sentinel Asset Management first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $8.29M in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.
- Sentinel Asset Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
- Sentinel Asset Management sold 40,000 Core Laboratories shares in Q4 2017, an estimated $3.95M.
- Sentinel Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
- Sentinel Asset Management's Core Laboratories position peaked at $8.29M in Q4 2016.
- 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.
Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.